Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

REMBTC

(REMBTC)

Unknown symbol
Date:
Sort by:
DateTimeSourceHeadlineSymbolCompany
06/02/20247:20AMPR Newswire (Canada)/R A P P E L -- Avis aux médias - Itinéraire de la vice-première ministre pour le dimanche 2 juin 2024/
06/02/20247:20AMPR Newswire (Canada)/R E M I N D E R -- Media Advisory - Deputy Prime Minister's itinerary for Sunday, June 2, 2024/
06/02/20247:00AMBusiness WireJune Joy at Juicy Stakes Casino
06/02/20247:00AMPR Newswire (Canada)/R E M I N D E R -- Media Advisory - Prime Minister's itinerary for Sunday, June 2, 2024/
06/02/20247:00AMPR Newswire (US)Fast Guard Service Releases Guide to Choosing the Best Fire Watch Service
06/02/20247:00AMPR Newswire (Canada)/R A P P E L -- Avis aux médias - Itinéraire du premier ministre pour le dimanche 2 juin 2024/
06/02/20246:41AMAlliance NewsAlliance NewsIsrael fights Hamas as mediators urge both to accept Gaza truce plan
06/02/20246:35AMAlliance NewsAlliance NewsOPEC+ anxious to maintain unity as some members head to Riyadh
06/02/20246:32AMAlliance NewsAlliance NewsDong Jun says Beijing ready to "forcefully" stop Taiwan independence
06/02/20246:29AMAlliance NewsAlliance NewsNvidia head, top chip CEOs to lay out AI plans at Taiwan expoTG:NVDNVIDIA Corp
06/02/20246:20AMAlliance NewsAlliance NewsPRESS: Sanofi proceeds with EUR20 billion consumer healthcare spin-off
06/02/20246:18AMPR Newswire (US)Sunvozertinib's Global Pivotal WU-KONG1B Study Meets Primary Endpoint in Non-Small Cell Lung Cancer with EGFR Exon 20 Insertion Mutations
06/02/20246:00AMPR Newswire (Canada)/R E P R I S E -- Avis aux médias - En pleine négociation, les intervenantes en petite enfance de la FIPEQ-CSQ participeront à l'activité de mobilisation de Ma place au travail/
06/02/20246:00AMPR Newswire (Canada)/R E P E A T -- Media Advisory: Infrastructure Announcement in Halifax/
06/02/20246:00AMPR Newswire (Canada)/R E P R I S E -- Avis aux médias : Annonce en matière d'infrastructure à Halifax/
06/02/20245:00AMPR Newswire (Canada)AVIS DE FERMETURE DE RUES : aujourd'hui, dimanche 2 juin, à l'occasion du Tour de l'Île de Montréal
06/02/20244:00AMGlobeNewswire Inc.BioCryst Presents New Real-world Evidence Showing Reductions in Attack Rates in HAE Patients with Normal C1-Inhibitor after Beginning ORLADEYO® (berotralstat) TreatmentNASDAQ:BCRXBioCryst Pharmaceuticals Inc
06/02/20242:08AMPR Newswire (Canada)Ontario Lottery and Gaming Corporation - EVENING LOTTERY WINNING NUMBERS - June 1, 2024
06/02/20242:00AMGlobeNewswire Inc.ePac Flexible Packaging Sets Strategy for Continued Double-Digit Growth
06/02/20242:00AMGlobeNewswire Inc.ePac Flexible Packaging Sets Strategy for Continued Double-Digit Growth
06/01/202411:56PMPR Newswire (US)Live from ASCO 2024 | Ascentage Pharma Releases Updated Data of FAK/ALK/ROS1 Inhibitor APG-2449 in Patients with NSCLC
06/01/202411:30PMPR Newswire (Canada)'A Red Cross for Journalism': Committee to Protect Journalists awarded Canadian Association of Journalists' 2024 Charles Bury Award
06/01/202411:30PMPR Newswire (Canada)« Une Croix-Rouge pour le journalisme » : Le Comité de protection des journalistes reçoit le prix Charles Bury 2024 de l'Association canadienne des journalistes
06/01/202411:30PMPR Newswire (Canada)L'Association canadienne des journalistes honore l'excellence du journalisme canadien de l'année écoulée lors de son gala annuel de remise de prix
06/01/202411:30PMPR Newswire (Canada)Canadian Association of Journalists celebrates excellence in Canadian journalism from the past year at annual awards gala
06/01/20248:25PMPR Newswire (US)Jacobio Pharma Presents SHP2 Plus KRAS G12C Data at ASCO
06/01/20248:17PMPR Newswire (US)CStone Announces European Medicine Agency CHMP Recommends Approval of Cejemly® (sugemalimab, anti-PD-L1) as First-Line Treatment for NSCLC
06/01/20248:15PMGlobeNewswire Inc.Heineken® Celebrates Thousands of ‘Real Hardcore Fans’ by Helping Them Take Part in the UEFA Champions League Final Trophy Celebrations For The First Time Ever
06/01/20247:13PMPR Newswire (US)GenFleet Therapeutics Announces Efficacy & Safety Result from Phase II Trial for First-line NSCLC Treatment in KROCUS Study, fulzerasib (KRAS G12C Inhibitor) in Combination with cetuximab, in a Late-breaking Abstract at the Oral Presentation of 2024 ASCO A
06/01/20246:09PMPR Newswire (US)LENNY KRAVITZ ROCKS OUT AT THE UEFA CHAMPIONS LEAGUE FINAL KICK OFF SHOW PRESENTED BY PEPSI®